The Effect of the Tongyang Huoxue Recipe (TYHX) on the Ito/IKur in Ischemia/Reperfusion Sinoatrial Node Cells

Wang, Yanli; Wu, Qiaomin; Liu, Jinfeng; Liu, Ruxiu

doi:https://doi.org/10.1155/2022/4114817

Cardiovascular Therapeutics

On this page

Abstract Introduction Materials and Methods Results Discussion Conclusions Data Availability Disclosure Conflicts of Interest Acknowledgments References Copyright Related Articles

Research Article | Open Access

Volume 2022 | Article ID 4114817 | https://doi.org/10.1155/2022/4114817

The Effect of the Tongyang Huoxue Recipe (TYHX) on the I_to/I_Kur in Ischemia/Reperfusion Sinoatrial Node Cells

Yanli Wang,¹Qiaomin Wu,¹Jinfeng Liu,¹and Ruxiu Liu¹

Academic Editor: Abhishesh Mehata

Received29 Jun 2022

Revised26 Sept 2022

Accepted23 Nov 2022

Published20 Dec 2022

Abstract

Background. The transient outward potassium current (I_to) and the ultrarapid delayed rectifier potassium current (I_Kur) are major potassium currents involved in the repolarization process of sinoatrial node cells (SNCs). Methods and Results. The SNCs of neonatal rats were divided into control, ischemia/reperfusion (I/R), I/R+blank serum, and Tongyang Huoxue recipe (TYHX) serum groups. I_to and I_Kur were recorded using the whole cell patch-clamp technique, and the current-voltage (I-V), steady-state activation (SSA), steady-state inactivation (SSI), and recovery from inactivation (RFI) curves were plotted, respectively. Compared to the control group, both the peak current density and the current density at the voltage of I_to and I_Kur decreased obviously in SNCs after simulated I/R, the SSA curves moved right, and the SSI curves moved left. After TYHX was added to the extracellular solution of SNCs, both the peak current density and the current density at the voltage of I_to and I_Kur increased significantly, the SSA curves moved left, and the SSI curves moved right with a significant difference of . The recovery from the I_Kur RFI curves was slightly restored, and the I_to curves did not change. Conclusions. TYHX increases the peak current density, accelerates the activation, and decreases the inactivation of the I_to and I_Kur. This may be the mechanism of TYHX in shortening the action potential duration of repolarization, which accelerates spontaneous pulsation.

1. Introduction

The sinoatrial node (SAN) is the primary cardiac pacemaker and the source of internal electrical stimulation driving the coordinated rhythmic contraction of the heart [1]. The SAN produces rhythmic cardiac pulsation due to its unique electrophysiological characteristics of the highest autonomic sinoatrial node cells (SNCs) and generates a spontaneous action potential (AP) that differs from peripheral atrial myocytes. SNCs are the active rhythmic cells of slow response potential with small AP, little resting potential, no platform, and only 0, 3, and 4 stages. The fourth stage of SNC, also named diastolic depolarization, a key to the SNC pacing activity, is unstable in spontaneous depolarization after repolarization.

The generation of action potentials in SNCs is achieved by the combined participation of various ionic currents across the cell membrane, including hyperpolarized activated cation current (I_f), potassium currents (I_K), calcium currents (I_Ca), and sodium-calcium exchange current (I_NCX) [1, 2]. The repolarization process of SNC ensures the spontaneous excitatory repetitive cycle of SAN. This inherent internal cycle enables SAN to serve the heart’s usual pacing. Transient outward potassium current (I_to) and ultrarapid delayed rectifier potassium current (I_Kur) are critical currents involved in the repolarization process of SNCs [3, 4]. Both are 4-aminopyridine (4-AP) sensitivity currents characterized by rapid activation and inactivation [5]. The abnormal SNC ion channels and currents can lead to severe sinus bradycardia or arrest [6, 7].

Tongyang Huoxue recipe (TYHX) is an effective prescription for treating bradyarrhythmias, developed by Liu Zhiming, a master of Chinese medicine. It comprises five traditional herbs: Astragalus membranaceus, ginseng, Rehmannia glutinosa, Angelica sinensis, and licorice [8]. Astragalus membranaceus is a traditional Chinese herbal medicine used for treating cardiovascular disease. It contains flavonoids, saponins, and polysaccharides known to have antioxidant and anti-inflammatory properties [9]. Ginseng is one of the most widely available and used botanicals from East to West [10]. It has well-established pharmacological properties, including heart protection, vasodilation, anticoagulation, and antistress activity [11]. Rehmannia glutinosa has been commonly used for antiaging and disease-preventing in China. Angelica sinensis has a broad spectrum of biological activities, such as producing blood, antiaging, and anti-inflammation [12]. Traditional medicinal licorice is a popular food plant in Europe and China, which can strengthen the effectiveness or reduce the toxicity of other ingredients [13]. In the TCM prescription, the reasonable compatibility of those medicinal materials plays a role in regulating heart rate. However, little is known about how TYHX is involved in action potential at the repolarization phase. Therefore, this study explored the effects of TYHX on I_to and I_Kur in SNCs and the gating kinetic mechanism to elucidate the cellular electrophysiological mechanism of TYHX in enhancing the pacing function of SNCs.

2. Materials and Methods

2.1. Ethics Statement

This study has been confirmed to the Guiding Principles for the Care and Use of Laboratory Animals issued by the National Committee of Science and Technology of China and was approved by the Institutional Animal Care and Use Committee, Guang’anmen Hospital (IACUC Issue No. IACUC-GAMH-2021-006).

2.2. Experimental Animals

Twenty male Wistar rats (body weight 300-350 g) were provided by the Center for Experimental Animals of the Academy of Military Medical Sciences (license number SCXK (Army) 2007-004, Beijing, China), and 200 Wistar neonatal rats (male or female) were purchased from SiBeiFu Laboratory Animal Science and Technology Co., Ltd. (license number SCXK (E) 2011-0004, Beijing, China).

2.3. Experimental Materials and Solutions

Tongyang Huoxue recipe, which was provided by Jiuding Pharmaceuticals Co., Ltd. (batch lot 20091210, Hunan, China), was used to make the medicated serum. Dulbecco’s modified Eagle medium (DMEM) was purchased from Invitrogen (United States); FBS and trypsin were purchased from GIBCO. 0.08% trypsin solution contained (g/L) 0.8 trypsin, 8 NaCl, 0.353 NaHCO₃, 0.991 glucose, 0.298 KCl, and 2 hydroxyethyl piperazine ethanesulfonic acid (HEPES). The simulation ischemic solution contained (in mmol/L) 98.5 NaCl, 10 KCl, 0.9 NaH₂PO₄, 6 NaHCO₃, 1.8 CaCl₂, 1.2 MgSO₄, 40 sodium lactate, and 20 HEPES (pH 6.8, adjusted with 1% hydrochloric acid). Simulated reperfusion solution contained (in mmol/L) 129.5 NaCl, 5 KCl, 0.9 NaH₂PO₄, 20 NaHCO₃, 1.8 CaCl2, 1.2 MgSO₄, 55 glucose, and 20 HEPES (pH 7.4, adjusted with 1 mmol/L NaOH). The internal pipette solution contained (in mmol/L) 130 KCl, 1 MgCl₂, 5.0 Na₂ATP, 5 ethylene glycol tetraacetic acid (EGTA), 10 HEPES, and 10 glucose (pH 7.2, adjusted with KOH), and the bath solution contained (in mmol/L) 140 NaCl, 1 MgCl₂, 1 CaCl2, 4 KCl, 10 HEPES, and 5 glucose (pH 7.36, adjusted with KOH).

2.4. Isolation, Purification, and Culture of SNCs

SNCs were isolated from five Wistar neonatal rats (<1 day) for each procedure, identified, and cultured as previously described [14, 15]. Rats were immersed in 75% ethanol for 5-10 seconds and then fixed in a supine position on a sterile bench. The front thoracic wall was cut open with straight ophthalmic scissors to expose the heart. Tissue blocks (0.7 mm³) were collected from the venous sinus in the middle portion of the crista terminalis and root of the anterior vena cava under the dissecting microscope and placed in DMEM without fetal bovine serum. After vigorous pipetting, the tissue blocks were grasped with curved ophthalmic forceps and washed with phosphate-buffered saline (PBS). The tissue blocks were then immersed in PBS and cut into chylomicron. The supernatant was aspirated, and the minced tissue pieces were digested with trypsin (0.8 g/L, Sigma, USA) for 5 min in a 37°C water bath under constant shaking, pipetted vigorously for 1 min, and precipitated. The supernatants were collected and transferred to 50 mL centrifuge tubes containing 20 mL of DMEM with 15% FBS. The precipitated tissue pieces were digested again, following the same procedure described above until they were completely digested. The samples were then filtered through 400-mesh metal sieves. The filtrates were transferred to centrifuge tubes and centrifuged at 940 r/min^-1 for 7 min. After centrifugation, the supernatants were discarded, and the cells were resuspended in a medium culture dish at a density of cells/L. The single cell suspension was inoculated into six small Petri dishes, divided into the control group, the I/R group, the blank serum group, and the TYHX serum group (100 μL). Then, they were taken into the incubator with 95% O₂ and 5% CO₂ at 37°C for cell attachment, and the DMEM was changed regularly. Fibroblasts were removed through differential adherence speed, and the remaining cells were spindle-shaped, which would be SAN cells.

2.5. Establishment of a Simulated I/R Model in SNCs

The I/R model was constructed according to the method developed by Koyama et al. [16] and our prophase research. Ischemia was simulated by oxygen-glucose deprivation (OGD), whereas reperfusion was simulated by restoring the oxygen and sugar supply. The culture medium was replaced by the presaturated simulated ischemia solution in 95% N₂+5% CO₂ and then cultured in a cell incubator containing 95% N₂ and 5% CO₂ for one hour. After that, the simulated ischemia solution was replaced with the simulated reperfusion solution with DMED containing 10% FBS cultured for three hours. Then, the SAN cells were subjected to patch-clamp experiments. All five other groups received the above I/R procedure except for the normal group.

2.6. Preparation of Tongyang Huoxue Recipe-Medicated Serum

Twenty adult male Wistar rats were divided into two groups, the control serum group and the TYHX-medicated serum group, with ten rats in each group. Wistar rats received intragastric administration for seven consecutive days, two times a day, according to an equivalent dose of the rat (in 200 g of body surface area) and the adult (in 70 kg of body surface area) [17]. The daily dose volume of TYHX extract for an adult human is 14.5 g; it is 1.3 g extract/kg converted into the equivalent dose for a rat. Ten times the dosage of the equivalent TYHX recipe dose was used in the rat, so the rat received a daily gavage volume of 13 g extract/kg. The TYHX extract was suspension compounded with distilled water, and the blank serum group received an equal volume of distilled water. Blood was collected by an abdominal aortic method. Centrifuge blood at 2500 r/min for 25 minutes to obtain serum. Then inactivate the serum in the water at 56°C for 30 minutes and sterilized using 0.22 μm microporous membrane filter. The sterile blank serum and the TYHX medicated serum were cryopreserved in the -80°C refrigerator for application.

2.7. Record the Potassium Current in SNCs

Patch-clamp experiments were performed as described in [18–20]. The whole-cell patch-clamp technique was used to record the potassium current using an Axopatch 700B amplifier (Axon Instruments, USA) with the pCLAMP 9.2 software (Axon Instruments, USA). Borosilicate glass patch pipettes () were pulled using a vertical pipette puller (Narishige PP-830, Japan). All the recordings were performed at room temperature (35°C) within 25 minutes to avoid the current rundown. The membrane capacitance was calculated using the manual whole-cell capacitance controls on the Axopatch amplifier.

The I_to and I_Kur were recorded in voltage-clamp mode under predefined protocols. To record the I_to current, the extracellular solution was added with dofetilide (5 nmol/L), CdCl₂ (100 μmol/L), tetrodotoxin (TTX, 100 μmol/L), and 4-aminopyridine (50 μmol/L) to block I_Kr, I_CaL, I_Na, and I_Kur channels, respectively. I_to was recorded in voltage-clamp mode with 300 ms pulses from a holding potential of -80 mV to test potentials between -40 and +50 mV in steps of 10 mV. To record the I_Kur current, the extracellular solution was added with dofetilide (5 nmol/L), CdCl₂ (100 μmol/L), tetrodotoxin (TTX, 100 μmol/L), and BaCl₂ (200 μmol/L) to block I_Kr, I_CaL, I_Na, and I_K1 channels, respectively. I_Kur was recorded in voltage-clamp mode with 2000 ms pulses from a holding potential of -80 mV to test potentials between -50 and +50 mV in steps of 10 mV. Each voltage pulse of I_to and I_Kur was preceded by a depolarization potential of -40 mV for 20 ms to inactivate Na⁺ currents. To learn more about gating mechanism of I_to and I_Kur, steady-state activation (SSA) and steady-state inactivation (SSI) curves were generated by the Boltzmann function, , where is the normalized current, is the membrane potential, is the voltage at midpoint of the available channels which are activated or inactivated, and is the slope factor of curves. The curves of recovery from inactivation were obtained by fitting the time course data to a simple exponential function.

2.8. Statistical Analysis

The data obtained were processed using Clampfit version 10.4 (Axon Instruments) and Origin version 8.0 (Micocal Software), and the measured data are expressed as . Multigroup comparisons were performed using one-way analysis of variance (ANOVA), and continuous univariate data were analyzed using a Student’s test. Steady-state activation and inactivation curves were fit with the Boltzmann function to obtain slope factor () and midpoint (). The time-dependent recovery from the inactivation was fit using a first-order exponential function. values less than 0.05 were considered statistically significant.

3. Results

3.1. Effects of TYHX on I_to and Its Gating Properties of SNCs

3.1.1. Effects of TYHX on the Peak Current of I_to

The peak current of I_to of SNC was found. To explore the effects of TYHX on the potassium current of SNC, we applied blank serum and TYHX-medicated serum to SNC. A significant reduction in the I_to current can be observed in the I/R group at the peak density (Figure 1(a)). After adding 100 μL blank serum, there was no obvious change at the I_to current’s peak density. TYHX-medicated serum application increased the peak density of I_to current from to , with significant change (Figure 1(b)). The results demonstrate that the simulated I/R reduced the peak current density of the I_to in the SAN cells. TYHX can increase the peak current density of the I_to and reverse the I/R-induced I_to changes in SAN cells.

(a)

(b)

3.1.2. Effects of TYHX on the Current and Current-Voltage (I-V) Curves of the I_to

Figure 2(a) shows the I_to current recorded after stimulation between voltages of -40 mV and +70 mV (10 mV depolarizing steps) from a holding potential of -80 mV. The I_to values corresponding to the above voltages were measured in each group, and I-V curves were constructed. The results showed (Figure 2(a)) that the current density increases as the stimulus pulse moves toward depolarization and shows a characteristic outward rectification. Figure 2(b) shows the function of TYHX on the current-voltage relationship of the transient outward current. After simulated I/R, the current densities in the SNCs decreased under each voltage, with statistical significance above the voltages of +20 mV () compared with the control group. The current densities of 100 μL TYHX serum under each voltage increased to different degrees, especially between the voltages of +10 mV and +70 mV with statistical significance () compared to the I/R group. There was no statistical difference between the blank serum group and the I/R group. The results indicated that the TYHX recipe-medicated serum could voltage dependently increase the current density of the I_to in SNCs.

(a)

(b)

3.1.3. Effects of TYHX on the SSA and SSI Curves of the I_to

We investigated the effects of TYHX on steady-state activation. Compared to the control group, the SSA curve of the I_to channel in the I/R group moved right of the depolarization direction. Besides, value (the steepness of the Boltzmann curve) was changed to from the (Figure 3(b)); , at which 50% of channels are activated, was changed to from the (Figure 3(c)) (). No significant difference in SSA curve, , and value was observed between the I/R group and 100 μL blank serum. After adding 100 μL TYHX serum, the SSA curve moved left (Figure 3(a)) and the was with statistical significance compared to the I/R group () (Figure 3(c)); however, the slope factor ( value) was with no difference () (Figure 3(b)). The results indicated that the simulated I/R decelerated the activation of I_to in SNCs. In contrast, the TYHX serum can accelerate the activation of the I_to and restore the current density.

(a)

(b)

(c)

(d)

(e)

(f)

In steady-state inactivation profiles, the leftward shift of the SSI in the I/R group indicated that simulated I/R accelerated deactivation. In the I/R group, the steepness of the SSI curve was changed from to (Figure 3(e)) () and the half-maximal inactivation voltage () was changed from to (Figure 3(f)) (). There was no significant difference in SSI and change between the I/R group and blank serum. TYHX serum produced a statistically significant right shift (Figure 3(d)) with of () (Figure 3(f)). The slope factor value was no different between the I/R, blank serum, and TYHX serum groups (Figure 3(e)). I_to channel inactivation acceleration leads to reduced current densities of the channels under the same depolarizing voltage. The results showed that TYHX serum can slow the inactivation of the I_to and restore the current density.

3.1.4. Effects of TYHX on the Recovery from Inactivation (RFI) Curves of the I_to Channel

Recovery from inactivation was assessed by a standard double-pulse protocol using a recovery potential of -100 mV. Data of recovery time was then fitted with a simple exponential function. While I_to was increased in TYHX application, we observed no difference in recovery from inactivation between all groups (Figure 4).

3.2. Effects of TYHX on I_Kur

3.2.1. Effects of TYHX on the Peak Current of I_Kur

The current of I_Kur was found in SNC. We determined the peak current density by measuring the peak I_Kur current as shown (Figure 5). The peak current of the I_Kur was significantly lower in the I/R group and 100 μL blank serum group, and the peak current increased after adding 100 μL TYHX serum (Figure 5(a)). No significant differences were found between the I/R group and 100 μL blank serum group. TYHX serum application increased the peak density of I_Kur current from to , with significant change () (Figure 5(b)). The above results demonstrate that the simulated I/R reduced the peak current density of the I_Kur in the SAN cells. The TYHX recipe can increase the peak current density of the I_Kur in damaged SAN cells and reverse I/R-induced I_Kur changes in SAN cells.

(a)

(b)

3.2.2. Effects of TYHX on the I-V Curves of the I_Kur

Figure 6 shows the I_Kur current recorded after stimulation between voltages of -40 mV and +70 mV (10 mV depolarizing steps) from a holding potential of -80 mV. The results showed (Figure 6) that the current density increases as the stimulus pulse moves toward depolarization and shows a characteristic outward rectification. After simulated I/R, the current densities in the SNCs decreased under each voltage, with a statistically significant difference between the voltages of +10 mV and +70 mV () compared with the control group. After adding 100 μL TYHX serum, we found that all current densities under each voltage increased to different degrees, especially between voltages of +20 mV and +70 mV, with statistical significance () compared to the I/R group. Nevertheless, there was no statistical difference between the blank serum group and the I/R group. The results indicated that I/R leads to decreased current density. The TYHX serum could increase the current density of the I_Kur in the SNCs with a voltage-dependent manner.

(a)

(b)

3.2.3. Effects of TYHX on the SSA and SSI Curves of the I_Kur

Fitted curves of steady-state activation and inactivation were generated by the Boltzmann function. In the I/R group, the SSA curve of the I_Kur channel moved right (Figure 7(a)). In details, the slope factor value changed from to () (Figure 7(b)), and the half-maximum activation voltage () was changed from to () (Figure 7(c)) with the statistical difference compared with the control group. After adding 100 μL TYHX serum, the SSA curve moved left, the value changed to , and the changed to , both with statistical significance compared to the I/R group () (Figures 7(b) and 7(c)). The results indicated that the simulated I/R decelerated the activation of the I_Kur to decrease the current density. And the TYHX serum can accelerate I_Kur activation and restore current density, thus may shorten the duration of repolarization of the SNC action potential and finally improving the autorhythmicity of SNCs.

(a)

(b)

(c)

(d)

(e)

(f)

In steady-state inactivation curves, the SSI curve moved left in the I/R group, accelerating the deactivation of I_Kur (Figure 7(d)). Comparisons between the I/R group and blank serum group showed no difference in slope factor value and . After adding TYHX, the SSI curve moved right, which means deactivation of I_Kur slowed (Figure 7(d)). The slope factor value changed from to after adding 100 μL TYHX serum () (Figure 7(e)). The data fitted a Boltzmann equation with values of and for the I/R group and after TYHX application, respectively (Figure 7(f)). The results indicated that the simulated I/R accelerated the inactivation of the I_Kur, which resulted left shift of SSI curves. On the contrary, the TYHX recipe can slow deactivation of the I_Kur and restore the current density to accelerate the repolarization.

3.2.4. The Recovery from Inactivation (RFI) Curves of the I_Kur

Recovery from inactivation is closely related to inactivation and critically determines I_Kur channel function. We observed slower recovery from inactivation in the I/R group compared to the control group, especially in the time of the former 3000 ms. The application of TYHX showed much faster deinactivation than the I/R group and blank group (Figure 8).

4. Discussion

Sick sinus syndrome (SSS) is an organic disease of SAN and its surrounding tissues, which leads to a series of clinical manifestations caused by pacing and impulsive efferent disturbance. It is a significant clinical refractory cardiovascular disease, manifested as bradycardia and conduction block, that can lead to the inadequate blood supply to the heart, brain, kidney, and other vital organs. The prevalence of SSS has been reported to be 1/1000 in adults over 45 years [21] and 1/600 in adults over 65 years of age [22]. Sudden cardiac arrest poses a severe threat to patients’ lives, and the number of new patients with SSS is expected to increase to 172,000 annually by 2060 in the United States [21]. SSS represents more than 50% of permanent pacemaker implantations globally [23].

Natural products have been globally recognized for having broad clinical application prospects in light of their advantages with respect to multitargets, efficacy advantages, and safety. With the rapid advances of modern technology, such as the patch clamp, we can evaluate a variety of Chinese antiarrhythmic medicines or their effective ingredients. Natural compounds are widely used in traditional Chinese medicine and have been verified to act on ion channels to alter ion channel gating against arrhythmia [24]. Previously, we elucidated that natural products of astragaloside could shorten the AP duration in damaged SAN cells of neonatal rabbits, thereby increasing the expression of HCN4 and the I_f current density in a voltage-dependent manner [25]. Components of TYHX were identified by previous high-performance liquid chromatography (HPLC) studies, and five significant components were confirmed, including ferulic acid, ginsenoside Rb1, astragaloside IV, diosgenin, and catalpol [8]. These components of TYHX have great potential for therapy and prevention in multiple cardiovascular diseases, including antioxidant, antiapoptotic, and anti-inflammatory effects [26, 27]. In addition, it can play a protective role for various cells (cardiomyocytes, sinoatrial node cells, and endothelial cells) under stress conditions [28–30].

The serum pharmacology method has been frequently used to study the effects and mechanisms of Chinese drugs in vitro, as it eliminates the interferences of the physical and chemical characteristics of crude herbs in the experimental process and provides similar experimental conditions to the in vivo environment. The results showed that blank serum from rats does not significantly affect the I_to and I_Kur current density or the process of activation and inactivation compared to the I/R group. Therefore, we used the method of serum pharmacology in vitro experiments and observed the effect of mediated serum on the regulation of I_to and I_Kur.

The abnormality of SNCs’ ion channels and currents can lead to SSS [31], in which I_to and I_Kur are critical currents involved in action potential repolarization of SNCs [32]. Changes in I_to and I_Kur affect the action potential duration and then affect the frequency of pulsation, which is of great significance to the regulation of action potential in SNCs. I_to in mammalian ventricular and atrial cells has been shown to be generated by K⁺ outward ions that largely contribute to the formation of the AP during the early repolarization phase (phase 1) [33]. A host of molecules modulate I_to, including Kv1.4, Kv4.2, and Kv4.3 channels. Some researchers have suggested that phase 1 of the AP in SAN cannot be identified. However, other studies showed that I_to significantly promoted the repolarization of rabbit sinoatrial node cells [34], and action potential duration (APD) was prolonged and current intensity was decreased in pacemaker cells when I_to-sensitive blocker 4-aminopyridine (4-AP) blocked I_to [32]. I_Kur also leads to rapid repolarization of the action potential and balances the inward depolarization current of Na + and L-type Ca²⁺ channels [35]. Block of I_Kur results in a 39% prolongation of the AP and a 27% increase in cycle length [36]. Kv1.5 (KCNA5) is believed to encode the pore-forming subunit of I_Kur [37], located at or close to desmosomes in SA node tissue [36]. An age-related decrease in Kv1.5 was found in the sinoatrial node of rats [38], which may partly explain the phenomenon that the duration of AP increases with aging [39]. As SSS is an aging disease, specific evidence is increasing for age-related remodeling of the ion channels in SAN [40].

I_to and I_Kur play an important role in regulating spontaneous cardiac rhythms and heart rate. The results of the present study show that TYHX increased the I_to and I_Kur current density in the damaged SAN cells in a voltage-dependent manner. The SSA curve of the I_to and I_Kur channels was shifted to the left, indicating that the TYHX treatment accelerated channel activation. The SSI curve of the I_to and I_Kur channel was shifted to the right, which illustrates TYHX slows the inactivation of I_to and I_Kur channel. The result estimated the possibility of TYHX in shorting the depolarization phase of the action potential and improving the autorhythmicity of SAN cells.

5. Conclusions

Our research elucidates the mechanism of TYHX in treating SSS from the aspect of cell electrophysiology. Combining with previous studies, our group systematically and intensely studied the clinical efficacy and mechanism of TYHX in the treatment of SSS from different levels, such as theoretical basis, animal experiment, holistic effect, cell molecule, and gene expression. It proved that TYHX has multiple goals and ways, playing an essential role in providing a scientific basis for the research methods and ideas for the treatment of diseases with TCM, which can deepen the scientific connotation of famous TCM experiences.

Data Availability

The data that support the findings of this study are available from the corresponding author upon reasonable request.

Disclosure

Yanli Wang and Qiaomin Wu are the co-first authors.

Conflicts of Interest

We declare that there is no conflict of interest regarding the publication of this paper.

Acknowledgments

We thank the technical assistance of the Institute of Geriatric Cardiovascular Disease, General Hospital of the Chinese People’s Liberation Army. The authors are grateful for the support from the Chinese National Natural Science Foundation and Beijing Natural Science Foundation. This work was supported by the National Natural Science Foundation of China (No. 81873293 and No. 81904045).

References

A. Kalyanasundaram, N. Li, B. J. Hansen, J. Zhao, and V. V. Fedorov, “Canine and human sinoatrial node: differences and similarities in the structure, function, molecular profiles, and arrhythmia,” Journal of Veterinary Cardiology, vol. 22, pp. 2–19, 2019.
View at: Publisher Site | Google Scholar
P. Mesirca, V. V. Fedorov, T. J. Hund et al., “Pharmacologic approach to sinoatrial node dysfunction,” Annual Review of Pharmacology and Toxicology, vol. 61, no. 1, pp. 757–778, 2021.
View at: Publisher Site | Google Scholar
J. W. Landaw, A. Garfinkel, J. N. Weiss, and Z. Qu, “Transient outward potassium current and its arrhythmogenic dynamics in cardiac myocytes,” Biophysical Journal, vol. 110, no. 3, p. 272a, 2016.
View at: Publisher Site | Google Scholar
Y. Cui, C. Wilson, S. Turner, S. Graham, N. McMahon, and B. Heath, “Possible role of the ultra-rapid delayed rectifier potassium current (IKur) in action potential repolarisation in rabbit heart,” Heart, vol. 97, no. 1, article e2, 2010.
View at: Publisher Site | Google Scholar
M. Lei, H. Honjo, I. Kodama, and M. R. Boyett, “Characterisation of the transient outward K+ current in rabbit sinoatrial node cells,” Cardiovascular Research, vol. 46, no. 3, pp. 433–441, 2000.
View at: Publisher Site | Google Scholar
A. Kojima and H. Matsuura, “Ionic mechanisms of the action of anaesthetics on sinoatrial node automaticity,” European Journal of Pharmacology, vol. 814, pp. 63–72, 2017.
View at: Publisher Site | Google Scholar
O. Monfredi, H. Dobrzynski, T. Mondal, M. R. Boyett, and G. M. Morris, “The anatomy and physiology of the sinoatrial node—a contemporary review,” Pacing and Clinical Electrophysiology, vol. 33, no. 11, pp. 1392–1406, 2010.
View at: Publisher Site | Google Scholar
X. Chang, S. Yao, Q. Wu, Y. Wang, J. Liu, and R. Liu, “Tongyang Huoxue decoction (TYHX) ameliorating hypoxia/reoxygenation-induced disequilibrium of calcium homeostasis and redox imbalance via regulating mitochondrial quality control in sinoatrial node cells,” Oxidative Medicine and Cellular Longevity, vol. 2021, Article ID 3154501, 20 pages, 2021.
View at: Publisher Site | Google Scholar
T. M. Holland, P. Agarwal, Y. Wang et al., “Dietary flavonols and risk of Alzheimer dementia,” Neurology, vol. 94, no. 16, pp. e1749–e1756, 2020.
View at: Publisher Site | Google Scholar
C. Yu, C. Z. Wang, C. J. Zhou et al., “Adulteration and cultivation region identification of American ginseng using HPLC coupled with multivariate analysis,” Journal of Pharmaceutical and Biomedical Analysis, vol. 99, pp. 8–15, 2014.
View at: Publisher Site | Google Scholar
D. Y. Lee, C. W. Park, S. J. Lee et al., “Anti-cancer effects of Panax ginseng berry polysaccharides via activation of immune-related cells,” Frontiers in Pharmacology, vol. 10, p. 1411, 2019.
View at: Publisher Site | Google Scholar
T. M. Lee, H. J. Harn, T. W. Chiou et al., “Remote transplantation of human adipose-derived stem cells induces regression of cardiac hypertrophy by regulating the macrophage polarization in spontaneously hypertensive rats,” Redox Biology, vol. 27, article 101170, 2019.
View at: Publisher Site | Google Scholar
Q. Y. Tan, Q. Hu, S. N. Zhu et al., “Licorice root extract and magnesium isoglycyrrhizinate protect against triptolide-induced hepatotoxicity via up-regulation of the Nrf2 pathway,” Drug Delivery, vol. 25, no. 1, pp. 1213–1223, 2018.
View at: Publisher Site | Google Scholar
Y.-K. Ju, J. Liu, B. H. Lee et al., “Distribution and functional role of inositol 1,4,5-trisphosphate receptors in mouse sinoatrial node,” Circulation Research, vol. 109, no. 8, pp. 848–857, 2011.
View at: Publisher Site | Google Scholar
W. Yanli, L. Ruxiu, L. Yu et al., “A method for isolating and identifying newbom rat sino-atrial node cells for patch-clamp study,” Journal of Southern Medical University, vol. 33, no. 3, pp. 397–400, 2013.
View at: Google Scholar
T. Koyama, K. Temma, and T. Akera, “Reperfusion-induced contracture develops with a decreasing [Ca2+]i in single heart cells,” The American Journal of Physiology, vol. 261, 4, Part 2, pp. H1115–H1122, 1991.
View at: Google Scholar
S. Xinyou, Modern Medical Laboratory Zoology: Determining and Calculating the Dosage of Laboratory Animals (in Chinese), People’s Military Medical Publishing House, Beijing, China, 2000.
L. Zhenwei, Practical Patch Clamp Technology, Military Medical Science Press, Beijing, China, 2006.
L. Yang and C. Rui, Ion Channeling, Hubei Science and Technology Press, Hubei, China, 2007.
O. P. Hamill, A. Marty, E. Neher, B. Sakmann, and F. J. Sigworth, “Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches,” Pflügers Archiv, vol. 391, no. 2, pp. 85–100, 1981.
View at: Publisher Site | Google Scholar
P. N. Jensen, N. N. Gronroos, L. Y. Chen et al., “Incidence of and risk factors for sick sinus syndrome in the general population,” Journal of the American College of Cardiology, vol. 64, no. 6, pp. 531–538, 2014.
View at: Publisher Site | Google Scholar
R. D. Rodriguez and D. D. Schocken, “Update on sick sinus syndrome, a cardiac disorder of aging,” Geriatrics, vol. 45, no. 1, 1990.
View at: Google Scholar
H. Dobrzynski, M. R. Boyett, and R. H. Anderson, “New insights into pacemaker activity,” Circulation Journal, vol. 115, no. 14, pp. 1921–1932, 2007.
View at: Publisher Site | Google Scholar
J. Li, D. Hu, X. Song, T. Han, Y. Gao, and Y. Xing, “The role of biologically active ingredients from natural drug treatments for arrhythmias in different mechanisms,” BioMed Research International, vol. 2017, Article ID 4615727, 10 pages, 2017.
View at: Publisher Site | Google Scholar
R. Liu, J. Li, Y. Liu, J. Peng, and X. Guan, “The effect of astragaloside on pacemaker current and the cytoskeleton in rabbit sinoatrial node cells under the ischemia and reperfusion condition,” Frontiers in Pharmacology, vol. 9, p. 551, 2018.
View at: Publisher Site | Google Scholar
C. Luo, Y. Zhang, H. Guo, X. Han, J. Ren, and J. Liu, “Ferulic acid attenuates hypoxia/reoxygenation injury by suppressing mitophagy through the PINK1/Parkin signaling pathway in H9c2 cells,” Frontiers in Pharmacology, vol. 11, p. 103, 2020.
View at: Publisher Site | Google Scholar
H. Peng, L. You, C. Yang et al., “Ginsenoside Rb1 attenuates triptolide-induced cytotoxicity in HL-7702 cells via the activation of Keap1/Nrf2/ARE pathway,” Frontiers in Pharmacology, vol. 12, article 723784, 2021.
View at: Publisher Site | Google Scholar
E. M. Neto-Neves, C. da Silva Maia Bezerra Filho, N. N. Dejani, and D. P. de Sousa, “Ferulic acid and cardiovascular health: therapeutic and preventive potential,” Mini Reviews in Medicinal Chemistry, vol. 21, no. 13, pp. 1625–1637, 2021.
View at: Publisher Site | Google Scholar
L. Jiang, X. Yin, Y. H. Chen et al., “Proteomic analysis reveals ginsenoside Rb1 attenuates myocardial ischemia/reperfusion injury through inhibiting ROS production from mitochondrial complex I,” Theranostics, vol. 11, no. 4, pp. 1703–1720, 2021.
View at: Publisher Site | Google Scholar
X. Li, S. Liu, L. Qu et al., “Dioscin and diosgenin: insights into their potential protective effects in cardiac diseases,” Journal of Ethnopharmacology, vol. 274, article 114018, 2021.
View at: Publisher Site | Google Scholar
G. Tse, T. Liu, K. H. C. Li et al., “Tachycardia-bradycardia syndrome: electrophysiological mechanisms and future therapeutic approaches (review),” International Journal of Molecular Medicine, vol. 39, no. 3, pp. 519–526, 2017.
View at: Publisher Site | Google Scholar
V. Golovko, M. Gonotkov, and E. Lebedeva, “Effects of 4-aminopyridine on action potentials generation in mouse sinoauricular node strips,” Physiological Reports, vol. 3, no. 7, article e12447, 2015.
View at: Publisher Site | Google Scholar
J. M. Nerbonne and R. S. Kass, “Molecular physiology of cardiac repolarization,” Physiological Reviews, vol. 85, no. 4, pp. 1205–1253, 2005.
View at: Publisher Site | Google Scholar
K.-i. Uese, N. Hagiwara, T. Miyawaki, and H. Kasanuki, “Properties of the transient outward current in rabbit sino-atrial node cells,” Journal of Molecular and Cellular Cardiology, vol. 31, no. 11, pp. 1975–1984, 1999.
View at: Publisher Site | Google Scholar
J. Tamargo, R. Caballero, R. Gómez, C. Valenzuela, and E. Delpón, “Pharmacology of cardiac potassium channels,” Cardiovascular Research, vol. 62, no. 1, pp. 9–33, 2004.
View at: Publisher Site | Google Scholar
H. Dobrzynski, S. M. Rothery, D. D. Marples et al., “Presence of the Kv1.5 K+channel in the sinoatrial node,” The Journal of Histochemistry and Cytochemistry, vol. 48, no. 6, pp. 769–780, 2000.
View at: Publisher Site | Google Scholar
W. Dun, N. Ozgen, M. Hirose et al., “Ionic mechanisms underlying region-specific remodeling of rabbit atrial action potentials caused by intermittent burst stimulation,” Heart Rhythm, vol. 4, no. 4, pp. 499–507, 2007.
View at: Publisher Site | Google Scholar
J. O. Tellez, M. Mczewski, J. Yanni et al., “Ageing-dependent remodelling of ion channel and Ca²⁺ clock genes underlying sino-atrial node pacemaking,” Experimental Physiology, vol. 96, no. 11, pp. 1163–1178, 2011.
View at: Publisher Site | Google Scholar
A. M. W. Alings and L. N. Bouman, “Electrophysiology of the ageing rabbit and cat sinoatrial node -- a comparative study,” European Heart Journal, vol. 14, no. 9, pp. 1278–1288, 1993.
View at: Publisher Site | Google Scholar
D. C. Bartos, E. Grandi, and C. M. Ripplinger, “Ion channels in the heart,” Comprehensive Physiology, vol. 5, no. 3, pp. 1423–1464, 2016.
View at: Google Scholar

Copyright

Copyright © 2022 Yanli Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

315

Downloads

350

Citations

Cardiovascular Therapeutics

The Effect of the Tongyang Huoxue Recipe (TYHX) on the Ito/IKur in Ischemia/Reperfusion Sinoatrial Node Cells

Abstract

1. Introduction

2. Materials and Methods

2.1. Ethics Statement

2.2. Experimental Animals

2.3. Experimental Materials and Solutions

2.4. Isolation, Purification, and Culture of SNCs

2.5. Establishment of a Simulated I/R Model in SNCs

2.6. Preparation of Tongyang Huoxue Recipe-Medicated Serum

2.7. Record the Potassium Current in SNCs

2.8. Statistical Analysis

3. Results

3.1. Effects of TYHX on Ito and Its Gating Properties of SNCs

3.1.1. Effects of TYHX on the Peak Current of Ito

3.1.2. Effects of TYHX on the Current and Current-Voltage (I-V) Curves of the Ito

3.1.3. Effects of TYHX on the SSA and SSI Curves of the Ito

3.1.4. Effects of TYHX on the Recovery from Inactivation (RFI) Curves of the Ito Channel

3.2. Effects of TYHX on IKur

3.2.1. Effects of TYHX on the Peak Current of IKur

3.2.2. Effects of TYHX on the I-V Curves of the IKur

3.2.3. Effects of TYHX on the SSA and SSI Curves of the IKur

3.2.4. The Recovery from Inactivation (RFI) Curves of the IKur

4. Discussion

5. Conclusions

Data Availability

Disclosure

Conflicts of Interest

Acknowledgments

References

Copyright

The Effect of the Tongyang Huoxue Recipe (TYHX) on the I_to/I_Kur in Ischemia/Reperfusion Sinoatrial Node Cells

3.1. Effects of TYHX on I_to and Its Gating Properties of SNCs

3.1.1. Effects of TYHX on the Peak Current of I_to

3.1.2. Effects of TYHX on the Current and Current-Voltage (I-V) Curves of the I_to

3.1.3. Effects of TYHX on the SSA and SSI Curves of the I_to

3.1.4. Effects of TYHX on the Recovery from Inactivation (RFI) Curves of the I_to Channel

3.2. Effects of TYHX on I_Kur

3.2.1. Effects of TYHX on the Peak Current of I_Kur

3.2.2. Effects of TYHX on the I-V Curves of the I_Kur

3.2.3. Effects of TYHX on the SSA and SSI Curves of the I_Kur

3.2.4. The Recovery from Inactivation (RFI) Curves of the I_Kur